Mirae Asset Global ETFs Holdings
RIGL icon

Mirae Asset Global ETFs Holdings’s Rigel Pharmaceuticals RIGL Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$297K Buy
11,100
+413
+4% +$13.9K ﹤0.01% 2159
2025
Q4 		$458K Buy
10,687
+1,886
+21% +$71.1K ﹤0.01% 1936
2025
Q3 		$250K Sell
8,801
-1,814
-17% -$54.3K ﹤0.01% 2210
2025
Q2 		$200K Sell
10,615
-751
-7% -$14.2K ﹤0.01% 2288
2025
Q1 		$204K Buy
11,366
+1,464
+15% +$29.7K ﹤0.01% 2309
2024
Q4 		$167K Buy
9,902
+278
+3% +$5.33K ﹤0.01% 2472
2024
Q3 		$156K Buy
9,624
+1,001
+12% +$11.8K ﹤0.01% 2492
2024
Q2 		$70.9K Buy
+8,623
New +$90.3K ﹤0.01% 2694

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's RIGL Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Rigel Pharmaceuticals (RIGL) stake by 3.9% in Q1 2026, buying an estimated $13.9K and bringing the position to 11,100 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #2159.

Mirae Asset Global ETFs Holdings first reported a position in RIGL in Q2 2024 and has held it in 8 quarters since. The position peaked at $458K in Q4 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 11,100 shares of Rigel Pharmaceuticals worth $297K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 413 Rigel Pharmaceuticals shares in Q1 2026, an estimated $13.9K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2159 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Rigel Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Rigel Pharmaceuticals position peaked at $458K in Q4 2025.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.